Targeting BRAF mutations in non-small cell lung cancer

The management of non-small cell lung cancer (NSCLC) has changed significantly with the discovery of specific drug targets. These drugs have helped transform patient care and outcomes. BRAF mutated NSCLC is now recognised as a rare form of lung cancer. Data has begun to emerge supporting the use of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transl Lung Cancer Res
Main Authors: O’Leary, Connor Gerard, Andelkovic, Vladamir, Ladwa, Rahul, Pavlakis, Nick, Zhou, Caicun, Hirsch, Fred, Richard, Derek, O’Byrne, Kenneth
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2019
Assuntos:
Review Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6976351/
https://ncbi.nlm.nih.gov/pubmed/32010589
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2019.10.22
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados